The CONTOO Portal       Congress Administration       Personal Account       Login/Logout       Privacy       Contact           
Poster and application for short presentation

Identification of the host cell receptor of Clostridium difficile toxin CDT

Panagiotis Papatheodorou1, Jan E. Carette2, George W. Bell3, Carsten Schwan4, Gregor Guttenberg5, Thijn R. Brummelkamp6, Klaus Aktories7
1 Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany
2 Department of Microbiology and Immunology, Stanford School of Medicine, Stanford, USA
3 Whitehead Institute for Biomedical Research, Cambridge, USA
4 Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany
5 Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany
6 The Netherlands Cancer Institute, Amsterdam, The Netherlands
7 Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany

Abstract

The human enteric pathogen Clostridium difficile is the most serious cause of antibiotic-associated diarrhea and pseudomembranous colitis. Hypervirulent strains of the pathogen, associated with more severe disease and increased death rates, produce the binary actin-ADP-ribosylating toxin CDT (Clostridium difficile transferase) in addition to the Rho glucosylating toxins A and B. CDT depolymerizes the actin cytoskeleton, increases adherence and colonization of Clostridia by induction of microtubule-based cell protrusions and, eventually, causes death of target cells. Using a haploid genetic screen, we identified the host cell receptor for binding and uptake of CDT by target cells. In addition, we present evidence that C. perfringens iota toxin, a related binary actin-ADP-ribosylating toxin, shares the same membrane receptor as CDT for cell entry. Identification of the host cell receptor of CDT provides a valuable basis for the development of new therapeutic strategies against CDT and related toxins.

DOI®: 10.3288/contoo.paper.1668
Please_wait